Paxlovid rebound

Fauci taking 2nd round of Paxlovid

You might remember that I recently wrote about my concerns over Immunological Original Sin, the problem of over-vaccinated people failing to make antibodies to the new variants of COVID and instead just making more of the obsolete antibodies.

Sometimes I hate being right.

Paxlovid works by stopping the virus from replicating for a while, it doesn’t eradicate it. But the idea is that by the time you finish the treatment, your body has had enough time to make antibodies that will.

But what if your body uses that time making the wrong antibodies? That is what happened to Fauci. So, Paxlovid only delayed the infection.

The FDA needs to get busy and get those bivalent vaccines to the marketplace with a new OWS type effort or it’s going to get ugly this fall.

Finally the really important decision

WSJ WVA v EPA

This is the one that mattered. More so than overturning Roe or even Bruen

While the decision is based on the EPA’s overreach on green house gases, it is a dagger to the heart of the regulatory state. For example, the FDA’s presumption that in regulating drugs they could also dictate the practice of medicine is on the chopping block.

When Congress delegates powers to regulators, it will have to be specific about what can be done.  Regulators will not be able to simply assume new powers on their own.

SCOTUS may yet save Biden from himself, by taking away his ability to screw up.